BioCentury
ARTICLE | Clinical News

Hybrigenics preclinical data

November 14, 2011 8:00 AM UTC

In vitro, HBX 19,818 significantly reduced the cell number of all CLL primary cell lines and cultures at concentrations that did not significantly affect the viability of control non-tumor peripheral ...